by 
Porcine vaccines are biological preparations used to establish or improve the immunity in pig population against various infectious diseases. Porcine vaccines help to reduce the incidence of diseases and improve growth efficiency in swine. Some of the key diseases addressed through porcine vaccines include foot-and-mouth disease, classical swine fever, porcine parvovirus, and porcine circovirus. Various types of vaccines available are killed vaccines, live attenuated vaccines, toxoid vaccines, and recombinant vector vaccines. The vaccines are usually administered through parenteral routes such as intramuscular and subcutaneous injections.
The global porcine vaccines market is estimated to be valued at US$ 2.4 Bn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The growth of global porcine vaccines market is driven by the increasing demand for pork meat and rise in swine farming globally. According to the World Bank, the global swine population increased from around 980 million heads in 2012 to over 1 billion heads in 2020.
Market Dynamics:
Rise in swine farming (as mentioned in heading) is one of the key drivers propelling the growth of global porcine vaccines market. Swine farming plays an important role in economic development as it generates income and employment opportunities in rural areas. Further, increasing population and changing dietary preferences have boosted the demand for pork meat worldwide. According to Organization for Economic Co-operation and Development and Food and Agriculture Organization, the annual global pork consumption is expected to grow from 119.4 million tons in 2016 to 143.7 million tons by 2027. This rising demand for pork translates to an increase in swine population which in turn drives the need for porcine vaccination globally to control infectious diseases and improve productivity. Further, increasing adoption of advanced vaccines such as subunit and DNA vaccines support the market growth over the forecast period.
Segment Analysis
The porcine vaccines market is segmented into live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines and recombinant vaccines. The live attenuated vaccines segment is dominating the market currently as it mimics natural infection and provides longer lasting immunity as compared to other vaccine types. The live attenuated vaccines are safe and cost-effective.
PEST Analysis
Political: Government support for research and development of new vaccines to prevent the spread of disease among livestock is boosting the market. Various regulations have been implemented for quality control and safety of porcine vaccines.
Economic: Rising meat consumption and growing pork production is increasing demand for vaccines to prevent economic losses from pig diseases. However, high R&D costs for new product development can hamper market growth.
Social: Rising awareness among farmers about benefits of vaccination is a key factor driving adoption. Preventing diseases helps ensure food safety and public health.
Technological: Advancements in vaccine technologies like recombinant technologies, DNA vaccines and improved adjuvants have increased efficacy and safety of porcine vaccines. This is positively impacting the market.
Key Takeaways
The global porcine vaccines market is expected to witness high growth over the forecast period of 2023 to 2030. The global porcine vaccines market is estimated to be valued at US$ 2.4 Bn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030.
Regional analysis related content comprises
The Asia Pacific region currently dominates the global porcine vaccines market accounting for over 35% share, led by China. China has largest pork production in the world meeting over half of the global demand. Growing meat consumption in India is also driving demand. The Europe market is second largest characterized by advanced animal husbandry practices and strict regulations for veterinary biologicals. North America market is mature and competitive with major global players present.
Key players related content comprises
Key players operating in the porcine vaccines market are Boehringer Ingelheim, Zoetis, Merck Animal Health, Bimeda, Elanco, Ceva, and Phibro Animal Health. The market leader Boehringer Ingelheim offers a wide range of vaccines like Ingelvac CircoFLEX, Ingelvac PRRS MLV etc. Zoetis markets vaccines like Circumvent PCV M G2 and Fostera PCV. Merck Animal Health provides vaccines like SUISENG. Key players are focused on launching new combination vaccines with improved efficacy to expand their market share and cater to rising demand.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
